Zahedan Journal of Research in Medical Sciences

Published by: Kowsar

Drug Resistance and Serotyping of Uropathogenic Escherichia coli Among Patients With Urinary Tract Infection in Rasht, Iran

Khosro Issazadeh 1 , * , Seyedeh Nasrin Naghibi 1 and Mohammad Reza Majid Khoshkholgh-Pahlaviani 2
Authors Information
1 Department of Microbiology, Faculty of Basic Sciences, Lahijan Branch, Islamic Azad University, Lahijan, IR Iran
2 Department of Biotechnology, Faculty of Basic Sciences, Lahijan Branch, Islamic Azad University, Lahijan, IR Iran
Article information
  • Zahedan Journal of Research in Medical Sciences: June 28, 2015, 17 (6)
  • Published Online: June 27, 2015
  • Article Type: Research Article
  • Received: April 9, 2014
  • Accepted: June 5, 2014
  • DOI: 10.17795/zjrms989

To Cite: Issazadeh K, Naghibi S N, Khoshkholgh-Pahlaviani M R M. Drug Resistance and Serotyping of Uropathogenic Escherichia coli Among Patients With Urinary Tract Infection in Rasht, Iran, Zahedan J Res Med Sci. 2015 ; 17(6):-. doi: 10.17795/zjrms989.

Abstract
Copyright © 2015, Zahedan University of Medical Sciences.This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Al Sweih N, Jamal W, Rotimi VO. Spectrum and antibiotic resistance of uropathogens isolated from hospital and community patients with urinary tract infections in two large hospitals in Kuwait. Med Princ Pract. 2005; 14(6): 401-7[DOI][PubMed]
  • 2. Kolawole AS, Kolawole OM, Kandaki-Olukemi YT, Babatunde SK, Durowade KA, Kolawole CF. Prevalence of urinary tract infections (UTI) among patients attending Dalhatu Araf Specialist Hospital, Lafia, Nasarawa State, Nigeria. Int j med sci. 2009; 1(5): 163-7
  • 3. Foxman B. The epidemiology of urinary tract infection. Nat Rev Urol. 2010; 7(12): 653-60[DOI][PubMed]
  • 4. Oliveira FA, Paludo KS, Arend LN, Farah SM, Pedrosa FO, Souza EM, et al. Virulence characteristics and antimicrobial susceptibility of uropathogenic Escherichia coli strains. Genet Mol Res. 2011; 10(4): 4114-25[DOI][PubMed]
  • 5. Vila J, Pal T. Update on antibacterial resistance in low-income countries: factors favoring the emergence of resistance~!2009-12-24~!2010-06-01~!2010-09-14~! The Open Infect Dis J. 2010; 4(2): 38-54[DOI]
  • 6. Farshad S, Ranjbar R, Japoni A, Hosseini M, Anvarinejad M, Mohammadzadegan R. Microbial susceptibility, virulence factors, and plasmid profiles of uropathogenic Escherichia coli strains isolated from children in Jahrom, Iran. Arch Iran Med. 2012; 15(5): 312-6[PubMed]
  • 7. Gyles CL, Fairbrother JM. Pathogenesis of bacterial infections in animals. 2010; : 267-308
  • 8. Marrs CF, Zhang L, Foxman B. Escherichia coli mediated urinary tract infections: are there distinct uropathogenic E. coli (UPEC) pathotypes? FEMS Microbiol Lett. 2005; 252(2): 183-90[DOI][PubMed]
  • 9. Azap OK, Arslan H, Serefhanoglu K, Colakoglu S, Erdogan H, Timurkaynak F, et al. Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections. Clin Microbiol Infect. 2010; 16(2): 147-51[DOI][PubMed]
  • 10. DeBusscher J, Zhang L, Buxton M, Foxman B, Barbosa-Cesnik C. Persistent extended-spectrum beta-lactamase urinary tract infection. Emerg Infect Dis. 2009; 15(11): 1862-4[DOI][PubMed]
  • 11. Dhakal BK, Kulesus RR, Mulvey MA. Mechanisms and consequences of bladder cell invasion by uropathogenic Escherichia coli. Eur J Clin Invest. 2008; 38 Suppl 2: 2-11[DOI][PubMed]
  • 12. Wiles TJ, Kulesus RR, Mulvey MA. Origins and virulence mechanisms of uropathogenic Escherichia coli. Exp Mol Pathol. 2008; 85(1): 11-9[DOI][PubMed]
  • 13. Abe CM, Salvador FA, Falsetti IN, Vieira MA, Blanco J, Blanco JE, et al. Uropathogenic Escherichia coli (UPEC) strains may carry virulence properties of diarrhoeagenic E. coli. FEMS Immunol Med Microbiol. 2008; 52(3): 397-406[DOI][PubMed]
  • 14. Yamamoto S. Molecular epidemiology of uropathogenic Escherichia coli. J Infect Chemother. 2007; 13(2): 68-73[DOI][PubMed]
  • 15. Johnson JR, Kuskowski MA, O'Bryan T T, Colodner R, Raz R. Virulence genotype and phylogenetic origin in relation to antibiotic resistance profile among Escherichia coli urine sample isolates from Israeli women with acute uncomplicated cystitis. Antimicrob Agents Chemother. 2005; 49(1): 26-31[DOI][PubMed]
  • 16. Johnson JR, Johnston B, Kuskowski MA, Colodner R, Raz R. Spontaneous conversion to quinolone and fluoroquinolone resistance among wild-type Escherichia coli isolates in relation to phylogenetic background and virulence genotype. Antimicrob Agents Chemother. 2005; 49(11): 4739-44[DOI][PubMed]
  • 17. Onanuga A, Oyi AR, Olayinka BO, Onaolapo JA. Prevalence of community-associated multi-resistant Staphylococcus aureus among healthy women in Abuja, Nigeria. African J Biotec. 2005; 4(9): 942-5
  • 18. von Baum H, Marre R. Antimicrobial resistance of Escherichia coli and therapeutic implications. Int J Med Microbiol. 2005; 295(6-7): 503-11[DOI][PubMed]
  • 19. Gupta K, Scholes D, Stamm WE. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA. 1999; 281(8): 736-8[PubMed]
  • 20. Kern WV, Oethinger M, Jellen-Ritter AS, Levy SB. Non-target gene mutations in the development of fluoroquinolone resistance in Escherichia coli. Antimicrob Agents Chemother. 2000; 44(4): 814-20[PubMed]
  • 21. Jones ME, Draghi DC, Thornsberry C, Karlowsky JA, Sahm DF, Wenzel RP. Emerging resistance among bacterial pathogens in the intensive care unit--a European and North American Surveillance study (2000-2002). Ann Clin Microbiol Antimicrob. 2004; 3: 14[DOI][PubMed]
  • 22. Korsakov F, Birch-Andersen AO. Fibril antigens in E. coli serotypes associated with pyelonephritis and cystitis. Scand J Infect Dis Suppl. 1982; 33: 18-25
  • 23. Blanco M, Blanco J, Blanco JE, Alonso MP, Abalia I, Rodriguez E, et al. [Virulence factors and 0 serogroups of Escherichia coli as a cause of community-acquired urinary infections]. Spanish. Enferm Infecc Microbiol Clin. 1995; 13(4): 236-41[PubMed]
  • 24. Mandal P, Kapil A, Goswami K, Das B, Dwivedi SN. Uropathogenic Escherichia coli causing urinary tract infections. Indian J Med Res. 2001; 114: 207-11[PubMed]
  • 25. Srikanth NS, Macaden R. Uropathogenic Escherichia coli--a preliminary study. Indian J Pathol Microbiol. 2003; 46(1): 145-6[PubMed]
  • 26. Vranes J, Schonwald S, sterk-Kuzmanovic N, Ivancic B. Low virulence of Escherichia coli strains causing exacerbation of chronic pyelonephritis. Acta Clinica Croatica. 2001; 40(3): 165-70
  • 27. Molina-Lopez J, Aparicio-Ozores G, Ribas-Aparicio RM, Gavilanes-Parra S, Chavez-Berrocal ME, Hernandez-Castro R, et al. Drug resistance, serotypes, and phylogenetic groups among uropathogenic Escherichia coli including O25-ST131 in Mexico City. J Infect Dev Ctries. 2011; 5(12): 840-9[PubMed]
  • 28. Zhao L, Chen X, Zhu X, Yang W, Dong L, Xu X, et al. Prevalence of virulence factors and antimicrobial resistance of uropathogenic Escherichia coli in Jiangsu province (China). Urology. 2009; 74(3): 702-7[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments